The University of California, San Francisco (UCSF), experience with topical carmustine (BCNU) in the treatment of approximately 200 patients with mycosis fungoides (MF) is summarized. Topical BCNU is an effective treatment for patch- and early plaque-stage MF. Side-effects are usually not a major deterrent to continuation of therapy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1396-0296.2003.01641.x | DOI Listing |
Publication Analysis
Top Keywords
topical carmustine
8
carmustine bcnu
8
bcnu treatment
8
mycosis fungoides
8
treatment mycosis
4
fungoides university
4
university california
4
california san
4
san francisco
4
francisco ucsf
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!